However, no studies examining Chk1 inhibition following PBT in HNSCC cell models are available, and also to our knowledge, there is no current evidence for the radiosensitising potential of Wee1 kinase inhibition in combination with PBT in any tumour type. This evidence concerns the gene CHEK1 and head and neck squamous cell carcinoma.